 ii Either disease progression following treatment with one prior chemotherapy regimen used for the treatment of metastatic disease or disease progression following adjuvantneoadjuvant therapy within one year of last dose of chemotherapy or for those patients with disease progression following adjuvantneoadjuvant therapy 1 year of last dose of chemotherapy disease progression following one additional chemotherapy regimen for metastatic disease. 